Neupogen and Bumetanide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Neupogen (filgrastim) and Bumetanide (bumetanide). Common drug interactions include dizziness postural among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Neupogen and Bumetanide. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

On Jul, 16, 2026

30 people who take Neupogen and Bumetanide together, and have interactions are studied.

Neupogen and Bumetanide drug interactions.

What are the common drug interactions of Neupogen and Bumetanide, by gender? *:

female:

Dizziness postural
Abdominal pain
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Methicillin-resistant staphylococcal aureus infection
Oedema peripheral (superficial swelling)
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
Acute respiratory distress syndrome
Adult respiratory distress syndrome (type of lung (pulmonary) failure)
Bacterial test positive
Blood bicarbonate increased

male:

Death
Thrombocytopenia (decrease of platelets in blood)
Acute graft versus host disease in liver (acute complication in liver following an allogeneic tissue/blood transplant)
Aspergillosis (an infection caused by a fungus called aspergillus)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac asthma (wheezing, coughing or shortness of breath due to congestive heart failure)
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Chronic kidney disease
Death unexplained
Decreased appetite

What are the common drug interactions of Neupogen and Bumetanide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Methicillin-resistant staphylococcal aureus infection
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
Acute respiratory distress syndrome
Adult respiratory distress syndrome (type of lung (pulmonary) failure)
Lower respiratory tract infection
Lung consolidation (a condition whereby the lung tissues solidify because of the accumulation of solid and liquid material in the air spaces)
Respiratory disorder (respiratory disease)
Respiratory tract infection
Vital capacity decreased

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

50-59:

Blood creatinine increased
Acute graft versus host disease in liver (acute complication in liver following an allogeneic tissue/blood transplant)
Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
Difficulty in walking
Fungal infection
Haematuria (presence of blood in urine)
Haematuria present (presence of blood in urine due to trauma)
Hepatotoxicity (chemical-driven liver damage)
Oedema lower limb (fluid collection in tissue of lower leg)
Renal failure acute (rapid kidney dysfunction)

60+:

Dizziness postural
Death
Rash
Respiratory tract infection
Aspergillosis (an infection caused by a fungus called aspergillus)
Bacterial test positive
Blood bicarbonate increased
Blood calcium decreased
Blood chloride decreased
Blood glucose increased

What are the existing conditions these people have? *

Pulmonary Hypertension Secondary (increase in blood pressure in the lung artery): 4 people, 13.33%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 13.33%
Asthma: 4 people, 13.33%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 3 people, 10.00%
Abdominal Pain Upper: 3 people, 10.00%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 6.67%
Multiple Myeloma (cancer of the plasma cells): 2 people, 6.67%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 6.67%
High Blood Pressure: 2 people, 6.67%
High Blood Cholesterol: 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Neupogen and Bumetanide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously